MDM2 and retinoblastoma: Here we investigate the p53 pathway in peripheral blood of patients with retinoblastoma, where results indicate that the level of the expression of RB, p53, and MDM2 mRNAs are significantly altered in the samples of patients, but not the levels of MDMX mRNA.